Pregabalin Extended-release Tablets 165?mg × 8 Tablets Rui Bei Hu

Pregabalin Extended-release Tablets 165?mg × 8 Tablets Rui Bei Hu

$1.00

Pregabalin Extended-release Tablets (brand name:  Rui Bei Hu) contain 165?mg of pregabalin per tablet. Supplied in 8-tablet packaging, this formulation is manufactured by Jiangsu Hengrui Pharmaceutical Co., Ltd.. Designed for sustained plasma levels in preclinical neurological studies, it is suitable for laboratory research in neuropathic pain, epilepsy, and generalized anxiety disorder models.?? For laboratory research use only.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare
分类:

描述

Pregabalin is a GABA-analog compound widely used in CNS research. The extended-release (ER) format supports longer half-life and more stable plasma levels in test models, making it valuable for chronic pain, seizure, and anxiety-related pharmacology.


Product Specifications

Parameter Details
Product Name Pregabalin Extended-release Tablets
Brand Name ??? (Rui Bei Hu)
Active Ingredient Pregabalin
CAS Number 148553-50-8
Molecular Formula C8H17NO2
Molecular Weight 159.23 g/mol
Strength 165?mg per tablet
Formulation Sustained-release (ER) oral tablets
Pack Size 8 tablets per box
Approval Number H20210042 (China NMPA)
Drug Code 86901445003321
Manufacturer Jiangsu Hengrui Pharmaceutical Co., Ltd.
Storage Conditions Store in cool, dry place (15–25°C); avoid light and moisture
Research Use For laboratory research only

Mechanism of Action

Pregabalin binds to the ?2? subunit of voltage-gated calcium channels in the CNS, reducing calcium influx and subsequently decreasing the release of excitatory neurotransmitters like glutamate and substance P. This mechanism contributes to its efficacy in models of neuropathic pain, epilepsy, and anxiety.


Research Applications

  • Neuropathic Pain Models
    Effective in sciatic nerve ligation, diabetic neuropathy, and spinal nerve transection models.

  • Epilepsy and Seizure Research
    Reduces seizure frequency in animal models with chemically or electrically induced epilepsy.

  • Anxiety and Depression Research
    Demonstrates anxiolytic properties in behavioral tests (e.g., elevated plus maze, light/dark box).

  • Chronic Pain/Inflammation
    Useful for long-term dosing due to extended-release formulation.


Safety & Handling

  • Handling Instructions: Use gloves and protective gear when preparing or handling tablets.

  • Storage: Keep sealed at room temperature in dry conditions.

  • Shelf Life: Generally stable for up to 36 months.

  • Toxicological Profile: Overexposure may result in dizziness, sedation, or behavioral changes in lab animals.


Research Use Disclaimer

This product is strictly intended for scientific laboratory research. It is not approved for therapeutic, diagnostic, or veterinary use. Misuse may result in health risks. Please follow institutional guidelines and local regulations when handling.

其他信息

重量 1.2 公斤
尺寸 52 × 43 × 52 厘米

评价

目前还没有评价

成为第一个“Pregabalin Extended-release Tablets 165?mg × 8 Tablets Rui Bei Hu” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

Q1: What is the difference between IR and ER pregabalin tablets?

A1: ER (Extended-release) tablets release pregabalin slowly over time, offering longer duration in research protocols without frequent re-dosing.

 

Q2: Is the product lab-grade?

A2: Yes, this version is intended exclusively for laboratory use, not for clinical or diagnostic purposes.

Q3: Can I request COA, MSDS, and other documentation?

A3: Yes, all technical documents (COA, SDS, TDS) are available upon request.

Q4: What animal models are commonly used with pregabalin?

A4: Rodent models for diabetic neuropathy, spinal nerve ligation, chronic constriction injury, and epilepsy.

Q5: Do you support OEM or bulk orders?

A5: Absolutely. We support OEM labeling and wholesale supply. Please contact us for pricing.


EMI Options

Select at least 2 products
to compare